Patent details
EP3436446 Title: MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
Basic Information
- Publication number:
- EP3436446
- PCT Application Number:
- US2017025381
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP177167632
- PCT Publication Number:
- WO2017173274
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- French Title of Invention:
- MODULATEURS DU RÉGULATEUR DE LA CONDUCTANCE TRANSMEMBRANAIRE DE LA FIBROSE KYSTIQUE
- German Title of Invention:
- MODULATOREN DES CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATORS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 07/06/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 12/06/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 07/06/2023
- Unitary Effect Registration Date:
- 12/06/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 31/03/2017
- Grant date:
- 07/06/2023
- EP Publication Date:
- 06/02/2019
- PCT Publication Date:
- 05/10/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/06/2023
- EP B1 Publication Date:
- 07/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 31/03/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/05/2023
- Name:
- Vertex Pharmaceuticals Incorporated
- Address:
- 50 Northern Avenue, Boston, MA 02210, United States (US)
Inventor
1
- Name:
- BEAR, Brian
- Address:
- United States (US)
2
- Name:
- MILLER, Mark, Thomas
- Address:
- United States (US)
3
- Name:
- CLEMENS, Jeremy
- Address:
- United States (US)
4
- Name:
- FRIEMAN, Bryan, A.
- Address:
- United States (US)
5
- Name:
- KRENITSKY, Paul, J.
- Address:
- United States (US)
6
- Name:
- UY, Johnny
- Address:
- United States (US)
7
- Name:
- COON, Timothy, Richard
- Address:
- United States (US)
8
- Name:
- HADIDA RUAH, Sara S.
- Address:
- United States (US)
9
- Name:
- CLEVELAND, Thomas
- Address:
- United States (US)
10
- Name:
- GROOTENHUIS, Peter, Diederik Jan
- Address:
- United States (US)
11
- Name:
- SILINA, Alina
- Address:
- United States (US)
12
- Name:
- KHATUYA, Haripada
- Address:
- United States (US)
13
- Name:
- ZHOU, Jinglan
- Address:
- United States (US)
Priority
- Priority Number:
- 201662316043 P
- Priority Date:
- 31/03/2016
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07D 401/14; C07D 213/82; A61P 11/00; A61K 31/44;
Publication
European Patent Bulletin
1
- Issue number:
- 202323
- Publication date:
- 07/06/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202328
- Publication date:
- 12/07/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202328
- Publication date:
- 12/07/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|